copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer
(Any information to deal,buy, sell, quote for products or service)
Patients - Hope For CKD by ProKidney For patients considering the PROACT 1 clinical trial, the decision involves weighing the benefits and challenges of participating in a research study against following established treatment protocols Here are some key points for you to consider as a patient:
Home - Hope For CKD by ProKidney Chronic kidney disease (CKD) affects approximately 14% of U S adults, equating to about 35 5 million people African Americans are more than 3 times as likely to have kidney failure compared to White Americans Latinos are 1 3X’s more likely to receive a diagnosis of kidney failure compared to the general population
ProKidney - Pioneers in the Treatment of Chronic Kidney Disease Together, we can leverage our capabilities to transform the Chronic Kidney Disease treatment lanscape and drive forward innovation We are currently conductive Phase 3 clinical trials for a transformative proprietary cell therapy with the potential for treating CKD
ProKidney Reports Statistically and Clinically Significant ProKidney has an upcoming FDA Type B meeting this summer to confirm the approach to using eGFR slope as the surrogate endpoint for accelerated approval Additional details are expected in